Prediction of interindividual differences in hepatic functions and drug sensitivity by using human iPS-derived hepatocytes.
about
Value of monitoring Nrf2 activity for the detection of chemical and oxidative stressStem cell-derived liver cells for drug testing and disease modelingPluripotent stem cell derived hepatocytes: using materials to define cellular differentiation and tissue engineeringDifferences in the Epigenetic Regulation of Cytochrome P450 Genes between Human Embryonic Stem Cell-Derived Hepatocytes and Primary HepatocytesStem cell-derived models to improve mechanistic understanding and prediction of human drug-induced liver injuryPatient-specific hepatocyte-like cells derived from induced pluripotent stem cells model pazopanib-mediated hepatotoxicityDonor-Dependent and Other Nondefined Factors Have Greater Influence on the Hepatic Phenotype Than the Starting Cell Type in Induced Pluripotent Stem Cell Derived Hepatocyte-Like Cells.The Promise and Challenge of Induced Pluripotent Stem Cells for Cardiovascular Applications.Characteristic Analysis of Intestinal Transport in Enterocyte-Like Cells Differentiated from Human Induced Pluripotent Stem Cells.CPM Is a Useful Cell Surface Marker to Isolate Expandable Bi-Potential Liver Progenitor Cells Derived from Human iPS Cells.Generation of enterocyte-like cells from human induced pluripotent stem cells for drug absorption and metabolism studies in human small intestineXeno-sensing activity of the aryl hydrocarbon receptor in human pluripotent stem cell-derived hepatocyte-like cells.Minireview: Genome Editing of Human Pluripotent Stem Cells for Modeling Metabolic Disease.Asialoglycoprotein receptor 1 is a specific cell-surface marker for isolating hepatocytes derived from human pluripotent stem cells.Cell sources for in vitro human liver cell culture models.Prediction of Differentiation Tendency Toward Hepatocytes from Gene Expression in Undifferentiated Human Pluripotent Stem Cells.Generation of a bile salt export pump deficiency model using patient-specific induced pluripotent stem cell-derived hepatocyte-like cellsHuman induced-pluripotent stem cell-derived hepatocyte-like cells as an in vitro model of human hepatitis B virus infection.Concise Review: Patient-Derived Stem Cell Research for Monogenic Disorders.Opportunities and challenges in using human hepatocytes in cytochromes P450 induction assays.Metabolic activation and drug-induced liver injury: in vitro approaches for the safety risk assessment of new drugs.A new era of disease modeling and drug discovery using induced pluripotent stem cells.Concise Review: Advances in Generating Hepatocytes from Pluripotent Stem Cells for Translational Medicine.Emerging In Vitro Liver Technologies for Drug Metabolism and Inter-Organ Interactions.Concise Review: Liver Regenerative Medicine: From Hepatocyte Transplantation to Bioartificial Livers and Bioengineered Grafts.One Standardized Differentiation Procedure Robustly Generates Homogenous Hepatocyte Cultures Displaying Metabolic Diversity from a Large Panel of Human Pluripotent Stem Cells.Human hepatocytes derived from pluripotent stem cells: a promising cell model for drug hepatotoxicity screening.Characterization of primary human hepatocyte spheroids as a model system for drug-induced liver injury, liver function and disease.Hepatic Differentiation of Human Induced Pluripotent Stem Cells in a Perfused Three-Dimensional Multicompartment Bioreactor.Footprint-free human fetal foreskin derived iPSCs: A tool for modeling hepatogenesis associated gene regulatory networks.Laminin-guided highly efficient endothelial commitment from human pluripotent stem cells.Sensitive and long-term monitoring of intracellular microRNAs using a non-integrating cytoplasmic RNA vector.Prediction of cytochrome P450-mediated drug clearance in humans based on the measured activities of selected CYPs.Direct conversion of human fibroblasts into hepatocyte-like cells by ATF5, PROX1, FOXA2, FOXA3, and HNF4A transduction.Pluripotent Stem Cell-Derived Human Tissue: Platforms to Evaluate Drug Metabolism and Safety.Paracrine signals regulate human liver organoid maturation from induced pluripotent stem cells.Human ESC/iPSC-Derived Hepatocyte-like Cells Achieve Zone-Specific Hepatic Properties by Modulation of WNT Signaling.Stem Cell Therapies for Treatment of Liver Disease.Hepatocyte Nuclear Factor 4 Alpha Promotes Definitive Endoderm Differentiation from Human Induced Pluripotent Stem Cells.Chemically induced hepatotoxicity in human stem cell-induced hepatocytes compared with primary hepatocytes and HepG2.
P2860
Q26778360-F776D200-CE4A-4C6B-AC78-826B4901A2D0Q27012605-FDBC2AF3-F410-4559-A48B-C7A88CC1AE53Q28076413-234C5A11-4F84-404A-BA72-8BAD3C2B43C8Q28546589-EB63211E-0180-4EBF-A86D-C6C6A4A2814DQ28818235-D65558B2-5C55-4AAF-B5DA-D486DC4AE3A9Q29247916-52199544-5A42-4589-AFC8-34EADBA697D1Q33722052-15328DBB-53F6-4A80-94C6-E5B9C68E5085Q33748399-769DC132-C2AA-4AFC-913E-CCA0463A8169Q36078060-A3E431BB-4A87-48E3-BCAB-90068C04AC89Q36221162-24436A95-F2A2-4E4D-8ED9-7DBEB3F05D08Q36272752-5D586CB4-9FAE-41A5-9B4F-7AF5E03F4E64Q36602403-3B8F8AE1-299F-4200-9EEB-817BBBB729CFQ36945218-B78CA5A1-83EE-40A8-B1A7-380D773A085FQ37009780-1E6E855E-E496-47DA-AEA9-4A5473EC3AC8Q37208518-E6FE78FD-6A39-467A-A8BB-4B2DDC80DA2AQ37513377-E63D6933-02DB-4269-8160-CDBB861A1D2AQ37620655-30358437-F2BC-44D0-946A-EAD2FF6A292DQ37736696-FD621DC2-6D86-4181-ACD8-C45C898C187EQ38557791-035958E7-E8AB-474F-ADA7-CE15AC979C19Q38650026-30204716-FCB3-48C8-B79C-AD87C04360B1Q38675826-4E8986D9-7BE5-4E3B-96D7-08769C7E27A9Q38786732-86FF8BEC-BDDB-440C-A4AD-33E78530B971Q38789231-84FCB933-F8BC-429B-B0D6-171896E3E87DQ38799238-EC70DC89-4BE7-4F4B-9E6B-790751912491Q38820033-5DC020D9-D5ED-46D6-BF0F-D6F349943DCAQ38834246-749E5D9C-0A01-4499-B1B2-5E792B9ABE03Q38871403-64631BD3-8B77-4EDA-86B4-2D48A1A680DCQ40770241-A6D6883B-86B8-41A3-A5D9-0719318A2CA9Q40965254-EF3082E4-C5B0-4CCE-B4E0-ECEC27634285Q41108782-64591866-0E81-42E2-9793-2C6004D03B8CQ41644327-C1B88E27-471D-4793-AADA-B48857A946DEQ41924081-E56E17E2-EB8B-423C-BFCF-CA731F33501DQ44677954-F85F710F-AC0C-4879-941D-A71ECD218627Q47218544-1256DF71-C5DC-46FB-93F4-0C3EF10A511BQ47225797-3CB13EF8-62CB-4AC9-BB2A-B7AD4A2FAF80Q48148269-AE58E65C-55A4-44AD-9788-6A4FFA5A0B12Q50893427-95BBA463-0448-45CE-9232-9E831E56B4B9Q51032622-70F0906C-EB58-4006-9DA9-E3B6CE22B93DQ51070593-885F9196-4646-43A9-80C1-84E6CF858589Q51708710-68EC955D-9E0D-4101-B774-D7A4B362580E
P2860
Prediction of interindividual differences in hepatic functions and drug sensitivity by using human iPS-derived hepatocytes.
description
2014 nî lūn-bûn
@nan
2014 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Prediction of interindividual ...... human iPS-derived hepatocytes.
@ast
Prediction of interindividual ...... human iPS-derived hepatocytes.
@en
Prediction of interindividual ...... human iPS-derived hepatocytes.
@nl
type
label
Prediction of interindividual ...... human iPS-derived hepatocytes.
@ast
Prediction of interindividual ...... human iPS-derived hepatocytes.
@en
Prediction of interindividual ...... human iPS-derived hepatocytes.
@nl
prefLabel
Prediction of interindividual ...... human iPS-derived hepatocytes.
@ast
Prediction of interindividual ...... human iPS-derived hepatocytes.
@en
Prediction of interindividual ...... human iPS-derived hepatocytes.
@nl
P2093
P2860
P50
P356
P1476
Prediction of interindividual ...... human iPS-derived hepatocytes
@en
P2093
Emiko Noguchi
Fuminori Sakurai
Hiroyuki Mizuguchi
Kazumasa Hirata
Kazuo Harada
Kazuo Imagawa
Ken Nishimura
Kenji Kawabata
Manami Ohtaka
Norihisa Furukawa
P2860
P304
16772-16777
P356
10.1073/PNAS.1413481111
P407
P577
2014-11-10T00:00:00Z